看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。" u+ q0 u- g7 L
" a0 ?; r( k6 m, q5 l8 p7 [9 ?+ s6 K6 P& r+ u3 K- B# R; p+ y4 A
Currently available feasibility data for possible combination strategies.
6 P! ~& |2 C) J2 }————————————————————————————————
- m4 B1 S9 w6 I# l, B/ S2 ZCombination Feasibility according to preliminary data ) |3 g$ o, x* l) f8 j
——————————————————————————————————! a2 H0 ?. q9 f" G( W& k( J
Bevacizumab + sorafenib Yes, reduced dose 6 X Y* q& o- l/ s' O6 |. p: o' i
Bevacizumab + sunitinib† No : k7 S3 n, [8 o6 \
Bevacizumab + temsirolimus Yes
) G8 V* X* C: ^8 bBevacizumab + everolimus Yes
4 \ V } |5 f0 CSorafenib + sunitinib ?
, @0 z# R, ? T: q1 ASorafenib + temsirolimus Yes, reduced dose
* m& i9 { d& ~/ a+ K: B. [% dSorafenib + everolimus Yes, reduced dose # P# U( l% p a$ W8 h9 ], h
Sunitinib + temsirolimus† No # f+ t: e9 {% O& S$ n* S
Sunitinib + everolimus ?
" x/ r1 T2 G% ]6 ?( |Temsirolimus + everolimus ? - X3 W0 ~' W$ j/ {! E
————————————————————
/ k- z5 V% ~6 O†Led to US FDA warning.* w. s: z3 P% F6 J; Q: m. _
?: As yet unattempted combination.. V2 K6 M( Y5 ~$ a( |2 f m
|